Immune Checkpoint Inhibitors Pose ACTH Deficiency Risk Immune Checkpoint Inhibitors Pose ACTH Deficiency Risk

Immune checkpoint inhibitors, increasingly used to treat a variety of cancers, can cause unpredictable immune-related adverse events including endocrinopathies.First Look
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Diabetes & Endocrinology News Source Type: news